Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal development

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Zhou, Zi Qiang ^a   Shung, Chia Yi ^a,b   Ota, Sara ^a   Akiyama, Haruhiko ^c   Keene, Douglas R ^a   Hurlin, Peter J ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; MUTANT PROTEIN; MYC PROTEIN; PEROXIREDOXIN 1; RNA POLYMERASE II; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR OSTERIX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; RUNX2 PROTEIN, MOUSE; SOX9 PROTEIN, MOUSE; VASCULOTROPIN A;

ALLELE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GROWTH; CARBOXY TERMINAL SEQUENCE; CARTILAGE CELL; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENCHONDRAL OSSIFICATION; GENE DELETION; GROWTH PLATE; HYPOPLASIA; LIMB BUD; LIMB DEVELOPMENT; MESENCHYME; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STEM CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANGIOGENESIS; ANIMAL; BIOLOGICAL MODEL; BONE; C57BL MOUSE; CELL COUNT; CELL DIFFERENTIATION; CONGENITAL MALFORMATION; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; MESODERM; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MUS;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE DELETION; GROWTH PLATE; LIMB BUDS; MESODERM; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-MYC; SOX9 TRANSCRIPTION FACTOR; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79954515222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018795     Document Type: Article

References (44)

1. Niswander L, (2003) Pattern formation: old models out on a limb. Nat. Rev. Genet 4: 133-143.
2. Tabin C, Wolpert L, (2007) Rethinking the proximodistal axis of the vertebrate limb in the molecular era. Genes Dev 21: 1433-1442.
3. ten Berge D, Brugmann SA, Helms JA, Nusse R, (2008) Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development 135: 3247-3257.
4. Thorogood PV, Hinchliffe JR, (1975) An analysis of the condensation process during chondrogenesis in the embryonic chick hind limb. J Embryol Exp Morphol 33: 581-606.
5. Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, et al. (2005) Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci U S A 102: 14665-14670.
6. Pearse RV, Scherz PJ, Campbell JK, Tabin CJ, (2007) A cellular lineage analysis of the chick limb bud. Dev Biol 310: 388-400.
7. Mackie EJ, Ahmed YA, Tatarczuch L, Chen K, Mirams M, (2008) Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40: 46-62.
8. Karsenty G, Kronenberg HM, Settembre C, (2009) Genetic control of bone formation. Annu Rev Cell Dev Biol 25: 629-648.
9. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B, (1999) Sox9 is required for cartilage formation. Nat Genet 22: 85-89.
10. Akiyama H, Chaboissier M, Martin JF, Schedl A, de Crombrugghe B, (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16: 2813-2828.
11. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
12. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
13. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
14. Zhou G, Zheng Q, Engin F, Munivez E, Chen Y, et al. (2006) Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci US A 103: 19004-19009.
15. Kim IS, Otto F, Zabel B, Mundlos S, (1999) Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 80: 159-170.
16. Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, et al. (2001) Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106: 97-106.
17. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F, (2000) Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113 (Pt 1): 59-69.
18. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, et al. (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
19. Maes C, Stockmans I, Moermans K, Van Looveren R, Smets N, et al. (2004) Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113: 188-199.
20. Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, et al. (2002) Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129: 1893-1904.
21. Colnot C, de la Fuente L, Huang S, Hu D, Lu C, et al. (2005) Indian hedgehog synchronizes skeletal angiogenesis and perichondrial maturation with cartilage development. Development 132: 1057-1067.
22. Joeng KS, Long F, (2009) The Gli2 transcriptional activator is a crucial effector for Ihh signaling in osteoblast development and cartilage vascularization. Development 136: 4177-4185.
23. Laurenti E, Wilson A, Trumpp A, (2009) Myc's other life: stem cells and beyond. Curr Opin Cell Biol 21: 844-854.
24. Eilers M, Eisenman RN, (2008) Myc's broad reach. Genes Dev 22: 2755-2766.
25. Ota S, Zhou Z, Keene DR, Knoepfler P, Hurlin PJ, (2007) Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development 134: 1583-1592.
26. Iwamoto M, Yagami K, Lu Valle P, Olsen BR, Petropoulos CJ, et al. (1993) Expression and role of c-myc in chondrocytes undergoing endochondral ossification. J Biol Chem 268: 9645-9652.
27. Quéva C, Hurlin PJ, Foley KP, Eisenman RN, (1998) Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene 16: 967-977.
28. Motoyama J, Eto K, (1994) Antisense c-myc oligonucleotide promotes chondrogenesis and enhances RA responsiveness of mouse limb mesenchymal cells in vitro. FEBS Lett 338: 323-325.
29. Piedra ME, Delgado MD, Ros MA, León J, (2002) c-Myc overexpression increases cell size and impairs cartilage differentiation during chick limb development. Cell Growth Differ 13: 185-193.
30. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, et al. (2001) c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414: 768-773.
31. Huang R, Christ B, Patel K, (2006) Regulation of scapula development. Anat Embryol 211 (Suppl 1): 65-71.
32. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, et al. (2002) Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33: 77-80.
33. Rodda SJ, McMahon AP, (2006) Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133: 3231-3244.
34. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, et al. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
35. Ornitz DM, (2005) FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16: 205-213.
36. Varlakhanova NV, Knoepfler PS, (2009) Acting locally and globally: Myc's ever-expanding roles on chromatin. Cancer Res 69: 7487-7490.
37. Murphy MJ, Wilson A, Trumpp A, (2005) More than just proliferation: Myc function in stem cells. Trends Cell Biol 15: 128-137.
38. Blanpain C, Fuchs E, (2009) Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10: 207-217.
39. Zhang C, Cho K, Huang Y, Lyons JP, Zhou X, et al. (2008) Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci USA 105: 6936-6941.
40. Malynn BA, de Alboran IM, O'Hagan RC, Bronson R, Davidson L, et al. (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14: 1390-1399.
41. Meyer N, Penn LZ, (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990.
42. Hirning U, Schmid P, Schulz WA, Rettenberger G, Hameister H, (1991) A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev 33: 119-125.
43. Knoepfler PS, Cheng PF, Eisenman RN, (2002) N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16: 2699-2712.
44. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, et al. (2007) HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134: 3917-3928.